Data / Form D filings / CareDx, Inc.
CareDx, Inc.: Form D filings
CareDx, Inc., a biotechnology company in Brisbane, CA, filed 4 Form D notices with the SEC between 2010 and 2016. The latest, on June 17, 2016, reports $22.2 million sold of a $36.8 million offering to 42 investors.
Find out what CareDx, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 3260 BAYSHORE BOULEVARD, Brisbane, CA, 94005
- Phone
- (415) 287-2300
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1217234
The full lists. Form D filings in California: 5,891 rows, $138.91, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jun 17, 2016 | Amendment | $36,802,008 | $22,169,135 | $14,632,873 | 42 | Apr 14, 2016 | sec.gov |
| Apr 28, 2016 | New notice | $36,802,008 | $14,169,129 | $22,632,879 | 39 | Apr 14, 2016 | sec.gov |
| Nov 15, 2011 | New notice | $2,928,943 | $2,155,781 | $773,162 | 31 | Oct 31, 2011 | sec.gov |
| Jul 12, 2010 | New notice | $10,000,000 | $6,041,511 | $3,958,489 | 48 | Jun 29, 2010 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| William Hagstrom | Director | |
| Ralph Snyderman | Director | |
| James Yee | Executive Officer | |
| Anders Karlsson | Executive Officer | |
| Todd Whitson | Executive Officer | |
| Michael Goldberg | Director | |
| Peter Maag | Executive Officer, Director | |
| John Sninsky | Executive Officer | |
| George Bickerstaff | Director | |
| Charles Constanti | Executive Officer | |
| Mitchell Nelles | Executive Officer | |
| Matthew Myer | Executive Officer | |
| Fred Cohen | Director |
Other biotechnology companies in California that filed recently
- CARI Health, Inc. $280,000 · Nov 6, 2026
- Ausel, Inc. $120,000 · Nov 4, 2026
- Trellis Bioscience, Inc. $9.1 million · Oct 29, 2026
- BigHat Biosciences, Inc. $75.1 million · Oct 26, 2026
- Theravie Pharma, Inc. $750,000 · Oct 19, 2026
- Adela, Inc. $12 million · Oct 19, 2026
Every Form D from the week of Jun 13, 2016 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what CareDx, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.